Type to search

NICE Recommends Novartis’ Piqray ® (Alpelisib) as a Targeted Treatment for Thousands of Advanced Breast Cancer Patients | Pharmtech Focus
Thousands Of Patients To Benefit As NHS Marks 100th Fast-Tracked Cancer Drug | Pharmtech Focus
Novartis Pharmaceuticals UK Launches World-first Health-tech Investor Partnership to Reimagine Cardiovascular Care | Pharmtech Focus